Current through September 17, 2024
Prior to prescribing, dispensing, or administering puberty
blocking drugs for the treatment of gender nonconformity or gender dysphoria to
a patient who has not reached the age of majority, the prescribing practitioner
must meet the following:
(A) Obtain
three hours of Category 1 Continuing Competency Education for prescribing drugs
for the purpose of treating gender nonconformity or gender dysphoria within the
most recent biennial renewal period;
(B) Determine or document:
(i) That gender nonconformity or gender
dysphoria is driving the patient's distress and not other mental or physical
health conditions, that there is no reasonable expectation of natural
resolution of gender nonconformity, and that there has been a long-lasting and
intense pattern of gender nonconformity or gender dysphoria which began or
worsened at the start of puberty;
(ii) The severity of other mental or physical
health conditions is being properly addressed and treated, and will not
negatively impact treatment;
(iii)
Puberty blocking treatment is not likely to negatively impact, or exacerbate
other mental or physical health conditions;
(iv) The patient has received at least 40
contact hours of therapeutic treatment as required by this chapter;
(v) The patient has at least six consecutive
months of living primarily as the preferred gender;
(vi) For individuals not suffering from
gender dysphoria or for whom a clinical diagnosis of gender dysphoria is not
available, that without puberty blocking treatment the patient will experience
harm;
(vii) Tanner stage of puberty
development and if puberty blockers would be effective; and
(viii) The appropriate supports are in place
for the patient including appropriate social, and familial supports prior to
initiating puberty blocking treatment;
(C) Discuss the following with the patient
and parent or legal guardian or the patient, if the patient is an emancipated
minor:
(i) The recommended dosage and route of
treatment for the puberty blockers; and
(ii) The minimum waiting period of seven calendar days as required
by this chapter;
(D)
Obtain signed informed consent and patient assent as required by this chapter;
and
(E) Document all the foregoing
in the patient's medical record.
